These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2459802)

  • 1. Contact activation of blood coagulation is inhibited by plasma factor XIII b-chain.
    Halkier T; Magnusson S
    Thromb Res; 1988 Aug; 51(3):313-24. PubMed ID: 2459802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histidine-rich glycoprotein inhibits contact activation of blood coagulation.
    Vestergaard AB; Andersen HF; Magnusson S; Halkier T
    Thromb Res; 1990 Dec; 60(5):385-96. PubMed ID: 2084959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the activation of bovine plasma factor XIII. Amino acid sequence of the peptide released by thrombin and the terminal residues of the subunit polypeptides.
    Nakamura S; Iwanaga S; Suzuki T
    J Biochem; 1975 Dec; 78(6):1247-66. PubMed ID: 1225922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway.
    Schousboe I
    Blood; 1985 Nov; 66(5):1086-91. PubMed ID: 4052628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays.
    Nuijens JH; Huijbregts CC; Cohen M; Navis GO; de Vries A; Eerenberg AJ; Bakker JC; Hack CE
    Thromb Haemost; 1987 Aug; 58(2):778-85. PubMed ID: 2445044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "A" subunit of factor XIII is present on bovine platelet membrane and mediates collagen-induced platelet activation.
    Kasahara K; Takagi J; Sekiya F; Inada Y; Saito Y
    Thromb Res; 1988 Apr; 50(2):253-63. PubMed ID: 2839910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL; Lukacova D
    Thromb Haemost; 1995 Aug; 74(2):680-5. PubMed ID: 8585006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative pathways for the activation of factor XIII.
    McDonagh J; McDonagh RP
    Br J Haematol; 1975 Aug; 30(4):465-77. PubMed ID: 1201228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of factor XIII a and b subunit in patients with disseminated intravascular coagulation syndrome].
    Sugimura D; Fukue H; Arai M; Matsumoto K; Fukutake K
    Rinsho Byori; 1996 Apr; 44(4):355-61. PubMed ID: 8847818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. b-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII.
    Mary A; Achyuthan KE; Greenberg CS
    Biochim Biophys Acta; 1988 Sep; 966(3):328-35. PubMed ID: 2901275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An equilibrium study of metal ion binding to human plasma coagulation factor XIII.
    Lewis BA; Freyssinet JM; Holbrook JJ
    Biochem J; 1978 Feb; 169(2):397-402. PubMed ID: 629762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ellagic acid/phospholipid-induced coagulation and dextran sulfate-induced fibrinolytic activities in beta 2-glycoprotein I-depleted plasma.
    Shiozaki A; Niiya K; Higuchi F; Tashiro S; Arai T; Izumi R; Sakuragawa N
    Thromb Res; 1994 Oct; 76(2):199-210. PubMed ID: 7863469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncatalytic subunits of human blood plasma coagulation factor XIII. Preparation and partial characterization of modified forms.
    Seelig GF; Folk JE
    J Biol Chem; 1980 Sep; 255(18):8881-6. PubMed ID: 7410400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.
    Muszbek L; Adány R; Mikkola H
    Crit Rev Clin Lab Sci; 1996; 33(5):357-421. PubMed ID: 8922891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of normal human peripheral blood monocytes and liver as sites of synthesis of coagulation factor XIII a-chain.
    Weisberg LJ; Shiu DT; Conkling PR; Shuman MA
    Blood; 1987 Aug; 70(2):579-82. PubMed ID: 3607290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of acetaldehyde on human plasma factor XIII function.
    Suchocki EA; Brecher AS
    Dig Dis Sci; 2007 Dec; 52(12):3488-92. PubMed ID: 17436086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation.
    Murtaugh PA
    Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.